Olin Biology (688319.SH): Trivalent Influenza Virus Split Vaccine (MDCK Cells) Approved for Clinical Trials
Olin Biology (688319.SH) announced that the company recently received the approval and issuance from the National Medical Products Administration...
Express News | Olin Biotech: Trivalent influenza virus split vaccine (MDCK cells) has received the Drug Clinical Trial Approval Letter.
Express News | Olin Biology's "Adsorbed Tetanus Vaccine" was selected as a fine industrial product in Chengdu.
Earnings Preview: Olin to Report Financial Results Post-market on October 24
$Olin(OLN.US)$ is scheduled to release its financial results post-market on October 24 ET. Earnings PreviewAnalysts estimate $Olin(OLN.US)$ to post revenue of USD1.58B for 2024Q3, down 5.42% YoY;
Earnings Preview: Olin (OLN) Q3 Earnings Expected to Decline
Wells Fargo Maintains Olin(OLN.US) With Hold Rating, Maintains Target Price $48